Jun 11, 2019Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL VialCommercial availability of NOCITA 10 mL vial size anticipated by fall 2019
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food...
Jun 7, 2019Stockholders Elect All Class III Directors and Approve Proposals
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting...
May 8, 2019Continued revenue growth across portfolio of marketed pet therapeutics
Aratana recorded $7.4 million in total revenues for the first quarter of 2019, including $2.5 million in NOCITA net product sales, $1.5 million in ENTYCE net product sales and $3.4 million in licensing and collaboration revenue from Elanco for GALLIPRANT.
May 7, 2019
The Company plans on presenting at the Stifel Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New York City.
Apr 26, 2019Elanco announces formation of commercial team dedicated to veterinary specialty business
The Company announced it has signed an agreement to be acquired by Elanco Animal Health (NYSE: ELAN), its global collaboration partner on GALLIPRANT® (grapiprant tablets). In conjunction with the transaction, Elanco also announced the formation of a commercial team dedicated to the veterinary specialty business. If the proposed agreement is consummated, the Aratana field force would transition into this commercial team.
Mar 12, 2019
The Company announced its fourth quarter and full year 2018 financial results and recent business highlights.
Feb 13, 2019
The Company plans on attending several upcoming investment conferences, including Bank of America Merrill Lynch Animal Health Summit, Cowen Health Care Conference and Barclays Global Healthcare Conference.
Feb 12, 2019
The Company will host a live conference call on Tuesday, March 12, 2019 at 4:30 p.m. ET to discuss financial results from the fourth quarter and full year ended December 31, 2018.
Feb 4, 2019
The Company announced the appointment of Rhonda Hellums as Chief Financial Officer and Treasurer of Aratana effective February 1, 2019.
Jan 17, 2019
The Company announced today the Board of Directors has appointed Craig Tooman to serve as President and Chief Executive Officer of Aratana, and elected Tooman to the Board of Directors.